Evidence map›Paper›PMID 39291771›Full record

ArticleAnnals of clinical and translational neurology2024

Language abnormalities in Alzheimer's disease indicate reduced informativeness.

Sabereh Bayat, Mahya Sanati, Mehrdad Mohammad-Panahi, Amirhossein Khodadadi, Mahdieh Ghasimi, Sahar Rezaee, Sara Besharat, Zahra Mahboubi-Fooladi, Mostafa Almasi-Dooghaee, Morteza Sanei-Taheri and 2 more

Abstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. The MINT Sprint 2.0: a Picture Naming Test for Detection of Naming Impairments in ΜCI Due or Not to AD, Greek Version.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sabereh BayatAzad University Science and Research Branch, Sattari Highway, Tehran, Iran.
Mahya SanatiAbrar Institute of Higher Education, Khorasan Square, Tehran, Iran.
Mehrdad Mohammad-PanahiInstitute for Cognitive Science Studies, Chamran Blvd, Tehran, Iran.
Amirhossein KhodadadiMashhad University of Medical Science, Vakil Abad Blvd, Mashhad, Iran.
Mahdieh GhasimiShahid Beheshti University of Medical Sciences, Velenjak, Daneshjoo Blvd, Tehran, Iran.
Sahar RezaeeShahid Beheshti University of Medical Sciences, Velenjak, Daneshjoo Blvd, Tehran, Iran.
Sara BesharatShahid Beheshti University of Medical Sciences, Velenjak, Daneshjoo Blvd, Tehran, Iran.
Zahra Mahboubi-FooladiShahid Beheshti University of Medical Sciences, Velenjak, Daneshjoo Blvd, Tehran, Iran.
Mostafa Almasi-DooghaeeIran University of Medical Sciences, Hemmat Highway, Tehran, Iran.
Morteza Sanei-TaheriShahid Beheshti University of Medical Sciences, Velenjak, Daneshjoo Blvd, Tehran, Iran.
Bradford C DickersonMassachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, USA.
Neguine RezaiiMassachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, USA.ORCID 0000-0002-8967-9237

Funding

The Harvard Clinical and Translational Science CenterUL1TR002541 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2018 to 2022
$93.0M
Toward Personalized Prognosis and Outcomes in Primary Progressive AphasiaRF1NS131395 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI DICKERSON, BRADFORD C · 2023 to 2023
$2.5M
Toward Personalized Prognosis and Outcomes in Primary Progressive AphasiaR01NS131395 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI BRADFORD C DICKERSON · 2026 to 2026
$824k
Use of machine learning to quantify cognitive function in AD, FTD, and DLBR21AG073744 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI DICKERSON, BRADFORD C, WOLFF, PHILLIP MARK · 2021 to 2022
$443k
Computational psycholinguistic analysis of speech samples in PPA and AD and FTDR21DC019567 · NIDCD · MASSACHUSETTS GENERAL HOSPITAL · PI DICKERSON, BRADFORD C, WOLFF, PHILLIP MARK · 2022 to 2023
$443k
Alzheimer's Association Clinician Scientist Fellowship (AACSF) 2022A015154MGH Screening Technologies in Primary Care Innovation Fund (PCIF) 2023A063002NCATS NIH HHS UL1 TR002541NCRR NIH HHSNIA NIH HHS R21 AG073744NIDCD NIH HHS R21 DC019567NIH HHS R01 NS131395NIH HHS R21 AG073744NIH HHS R21 DC019567NIH HHS UL1 TR002541NINDS NIH HHS RF1 NS131395
6 · The paper itself

Abstract

objectiveThis study aims to elucidate the cognitive underpinnings of language abnormalities in Alzheimer's Disease (AD) using a computational cross-linguistic approach and ultimately enhance the understanding and diagnostic accuracy of the disease.

methodsComputational analyses were conducted on language samples of 156 English and 50 Persian speakers, comprising both AD patients and healthy controls, to extract language indicators of AD. Furthermore, we introduced a machine learning-based metric, Language Informativeness Index (LII), to quantify empty speech.

resultsDespite considerable disparities in surface structures between the two languages, we observed consistency across language indicators of AD in both English and Persian. Notably, indicators of AD in English resulted in a classification accuracy of 90% in classifying AD in Persian. The substantial degree of transferability suggests that the language abnormalities of AD do not tightly link to the surface structures specific to English. Subsequently, we posited that these abnormalities stem from impairments in a more universal aspect of language production: the ability to generate informative messages independent of the language spoken. Consistent with this hypothesis, we found significant correlations between language indicators of AD and empty speech in both English and Persian.

interpretationThe findings of this study suggest that language impairments in AD arise from a deficit in a universal aspect of message formation rather than from the breakdown of language-specific morphosyntactic structures. Beyond enhancing our understanding of the psycholinguistic deficits of AD, our approach fosters the development of diagnostic tools across various languages, enhancing health equity and biocultural diversity.

Indexed as

Alzheimer DiseaseLanguage DisordersAgedAged, 80 and overFemaleHumansLanguageMachine LearningMaleMiddle Aged

Identifiers

PMID39291771
PMCPMC11572728

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.